TERT and cancer: The most frequent noncoding somatic mutations in cancers are mutations in the promoter of the telomerase catalytic subunit TERT (TERTp), which can be found in up to 90% of glioblastomas (Barthel et al. 2017, Horn et al. 2013, Huang et al. 2013).